Antipsychotic drugs are central to the treatment of schizophrenia and other psychotic
disorders but are ineffective for some patients and associated with side-effects and …

Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia
(HPRL) as a common adverse effect of antipsychotic medication, which remains the …

Physical disorders are, compared to the general population, more prevalent in people with
severe mental illness (SMI). Although this excess morbidity and mortality is largely due to …

These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …

Antipsychotic polypharmacy in schizophrenia is much debated, since it is common and
costly with unclear evidence for its efficacy and safety. We conducted a systematic literature …

Cancer is one of notorious diseases across the globe. Therapeutic approaches for cancer
are often expensive and develop severe side effects, and usually result comorbidities …

One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …

A limited number of studies have evaluated sexual functioning in patients with
schizophrenia. Most patients show an interest in sex that differs little from the general …

Prolactinomas are the most common pituitary adenomas (approximately 40% of cases), and
they represent an important cause of hypogonadism and infertility in both sexes. The …

Antipsychotic polypharmacy refers to the co-prescription of more than one antipsychotic drug
for an individual patient. Surveys of prescribing in psychiatric services internationally have …